Literature DB >> 7356901

The pharmacokinetics of methimazole in pregnant patients after oral administration of carbimazole.

G G Skellern, B I Knight, M Otter, C K Low, W D Alexander.   

Abstract

1 A high performance liquid chromatographic (HPLC) method was used to study the pharmacokinetics of methimazole after oral administration of carbimazole to women in various stages of pregnancy. 2 In one patient it was possible to conduct the study in the first and third timesters: there was an appreciable increase in the apparent clearance of methimazole. 3 Based on the assumption of complete absorption and hydrolysis of carbimazole to methimazole the mean apparent clearance was found to be significantly higher in pregnant patients receiving 10 mg carbimazole than in non-pregnant patients receiving the same dose.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7356901      PMCID: PMC1429862          DOI: 10.1111/j.1365-2125.1980.tb05824.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  6 in total

Review 1.  Drug kinetics in pregnancy.

Authors:  B Krauer; F Krauer
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

2.  Hyperthyroidism associated with pregnancy.

Authors:  L G Goluboff; J C Sisson; J I Hamburger
Journal:  Obstet Gynecol       Date:  1974-07       Impact factor: 7.661

3.  Antiepileptic drugs: metabolism in pregnancy.

Authors:  M Dam; J Christiansen; O Munck; K I Mygind
Journal:  Clin Pharmacokinet       Date:  1979 Jan-Feb       Impact factor: 6.447

4.  The placental transfer of propylthiouracil, methimazole and carbimazole.

Authors:  B Marchant; B E Brownlie; D M Hart; P W Horton; W D Alexander
Journal:  J Clin Endocrinol Metab       Date:  1977-12       Impact factor: 5.958

Review 5.  Drug metabolism in thyroid disease.

Authors:  M Eichelbaum
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

6.  The pharmacokinetics of methimazole after oral administration of carbimazole and methimazole, in hyperthyroid patients.

Authors:  G G Skellern; B I Knight; C K Low; W D Alexander; D G McLarty; W J Kalk
Journal:  Br J Clin Pharmacol       Date:  1980-02       Impact factor: 4.335

  6 in total
  7 in total

1.  Effect of pregnancy on a measure of FMO3 activity.

Authors:  Janne Hukkanen; Delia Dempsey; Peyton Jacob; Neal L Benowitz
Journal:  Br J Clin Pharmacol       Date:  2005-08       Impact factor: 4.335

2.  Hyperthyroidism and pregnancy. An Italian Thyroid Association (AIT) and Italian Association of Clinical Endocrinologists (AME) joint statement for clinical practice.

Authors:  R Negro; P Beck-Peccoz; L Chiovato; P Garofalo; R Guglielmi; E Papini; M Tonacchera; F Vermiglio; P Vitti; M Zini; A Pinchera
Journal:  J Endocrinol Invest       Date:  2011-03-22       Impact factor: 4.256

3.  A survey of pharmacokinetic data from pregnant women.

Authors:  A J Cummings
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

Review 4.  Pharmacokinetics of antithyroid drugs.

Authors:  G Benker; D Reinwein
Journal:  Klin Wochenschr       Date:  1982-06-01

5.  The metabolism of methimazole in pregnancy.

Authors:  J Kampmann; J M Hansen
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

Review 6.  Clinical pharmacokinetics of antithyroid drugs.

Authors:  J P Kampmann; J M Hansen
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

7.  Labetalol disposition and concentration-effect relationships during pregnancy.

Authors:  P C Rubin; L Butters; A W Kelman; C Fitzsimons; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.